Key statistics
On Monday, Xeris Biopharma Holdings Inc (2B30:DUS) closed at 4.02, -0.89% below its 52-week high of 4.06, set on Mar 06, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.83 |
---|---|
High | 4.02 |
Low | 3.78 |
Bid | -- |
Offer | -- |
Previous close | 3.83 |
Average volume | 1.53k |
---|---|
Shares outstanding | 153.94m |
Free float | 143.24m |
P/E (TTM) | -- |
Market cap | 652.71m USD |
EPS (TTM) | -0.3761 USD |
Data delayed at least 15 minutes, as of Mar 10 2025 18:30 BST.
More ▼
Press releases
- Xeris Biopharma Delivers Record Fourth Quarter and Full-Year 2024 Results; and Announces 2025 Guidance
- Xeris Biopharma to Report Fourth Quarter and Full-Year 2024 Financial Results on March 6, 2025
- Xeris Appoints Anh Nguyen, MD, MBA as Chief Medical Officer
- Xeris to Participate in Upcoming Investor Conferences
- Xeris Expects to Exceed Full-Year 2024 Financial Guidance
- Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
More ▼